Eduard Gallardo
Eduard Gallardo
Investigador Titular, Institut de Recerca Hospital de la Santa Creu i Sant Pau
Dirección de correo verificada de santpau.cat
TítuloCitado porAño
Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization
C Gómez-Moutón, JL Abad, E Mira, RA Lacalle, E Gallardo, ...
Proceedings of the National Academy of Sciences 98 (17), 9642-9647, 2001
5222001
miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
E Gallardo, A Navarro, N Viñolas, RM Marrades, T Diaz, B Gel, A Quera, ...
Carcinogenesis 30 (11), 1903-1909, 2009
3412009
Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy
J Bellmunt, L Paz-Ares, M Cuello, FL Cecere, S Albiol, V Guillem, ...
Annals of Oncology 18 (3), 522-528, 2007
2952007
Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype
I Illa, C Serrano‐Munuera, E Gallardo, A Lasa, R Rojas‐García, J Palmer, ...
Annals of Neurology: Official Journal of the American Neurological …, 2001
2682001
Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre …
J Garcia-Donas, E Esteban, LJ Leandro-García, DE Castellano, ...
The lancet oncology 12 (12), 1143-1150, 2011
2372011
The TREAT‐NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations
CL Bladen, D Salgado, S Monges, ME Foncuberta, K Kekou, K Kosma, ...
Human mutation 36 (4), 395-402, 2015
2312015
Long-lasting treatment effect of rituximab in MuSK myasthenia
J Diaz-Manera, E Martínez-Hernández, L Querol, R Klooster, ...
Neurology 78 (3), 189-193, 2012
2302012
Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium
J Bellmunt, V Guillem, L Paz-Ares, JL Gonzalez-Larriba, J Carles, ...
Journal of clinical oncology 18 (18), 3247-3255, 2000
2102000
Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients
E Gallardo, R Rojas–García, N De Luna, A Pou, RH Brown, I Illa
Neurology 57 (11), 2136-2138, 2001
1942001
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg
L Querol, G Nogales-Gadea, R Rojas-Garcia, J Diaz-Manera, J Pardo, ...
Neurology 82 (10), 879-886, 2014
1882014
Antibodies to contactin‐1 in chronic inflammatory demyelinating polyneuropathy
L Querol, G Nogales‐Gadea, R Rojas‐Garcia, E Martinez‐Hernandez, ...
Annals of neurology 73 (3), 370-380, 2013
1802013
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial
JC Araujo, GC Trudel, F Saad, AJ Armstrong, YY Evan, J Bellmunt, ...
The lancet oncology 14 (13), 1307-1316, 2013
1712013
Acute axonal Guillain‐Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides
I Illa, N Ortiz, E Gallard, C Juarez, JM Grau, MC Dalakas
Annals of neurology 38 (2), 218-224, 1995
1611995
Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo
F Lluı́s, J Roma, M Suelves, M Parra, G Aniorte, E Gallardo, I Illa, ...
Blood 97 (6), 1703-1711, 2001
1232001
Charcot–Marie–Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles
E Gallardo, A García, O Combarros, J Berciano
Brain 129 (2), 426-437, 2005
1222005
A novel, blood‐based diagnostic assay for limb girdle muscular dystrophy 2B and Miyoshi myopathy
M Ho, E Gallardo, D McKenna‐Yasek, N De Luna, I Illa, RH Brown Jr
Annals of Neurology: Official Journal of the American Neurological …, 2002
1182002
Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients
I Illa, J Diaz-Manera, R Rojas-Garcia, J Pradas, A Rey, R Blesa, C Juarez, ...
Journal of neuroimmunology 201, 90-94, 2008
1112008
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins
L Querol, R Rojas-García, J Diaz-Manera, J Barcena, J Pardo, ...
Neurology-Neuroimmunology Neuroinflammation 2 (5), e149, 2015
1082015
Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: baseline interleukin-8 and tumor contrast …
J Bellmunt, JL Gonzalez-Larriba, C Prior, P Maroto, J Carles, ...
Annals of oncology 22 (12), 2646-2653, 2011
1062011
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution …
V Conteduca, D Wetterskog, MTA Sharabiani, E Grande, ...
Annals of Oncology 28 (7), 1508-1516, 2017
992017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20